Skip to main content

Table 3 Methodological quality of included reviews. (AMSTAR-2a)

From: Patients’ perceptions with musculoskeletal disorders regarding their experience with healthcare providers and health services: an overview of reviews

Reviews

Q1

Q2c

Q3

Q4

Q5

Q6

Q7

Q8

Q9c

Q10

Q11c

Q12c

Q13c

Q14

Q15c

Q16

Qualityb

Scoping reviews

 Hopayian, 2014 [47]

Y

NA

N

PY

Y

Y

N

PY

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Zuidema, 2015 [38]

Y

NA

N

PY

Y

Y

N

N

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Wluka, 2016 [54]

Y

NA

N

PY

N

N

N

PY

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Chou, 2017 [21]

Y

NA

N

PY

Y

Y

N

Y

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Papandony, 2017 [22]

Y

NA

N

PY

Y

Y

N

Y

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Gillespie, 2017 [46]

Y

NA

N

PY

Y

Y

N

PY

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Chou, 2018 [19]

Y

NA

N

PY

Y

N

N

Y

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Chou, 2018 [20]

Y

NA

Y

PY

Y

Y

N

Y

NA

N

NA

NA

NA

N

NA

Y

Moderate

 Chou, 2018 [25]

Y

NA

Y

PY

Y

Y

N

Y

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Segan, 2018 [26]

Y

NA

Y

PY

N

N

N

PY

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Chou, 2018 [52]

Y

NA

Y

PY

Y

N

N

PY

NA

N

NA

NA

NA

Y

NA

Y

Moderate

 Asif, 2019 [55]

Y

NA

N

PY

Y

N

N

PY

NA

Y

NA

NA

NA

Y

NA

Y

Moderate

Systematic reviews

 Verbeek, 2004 [50]

Y

N

N

PY

N

Y

N

PY

N

N

NA

NA

N

Y

NA

Y

Low

 Slade, 2010 [23]

Y

N

Y

PY

N

N

N

N

N

N

NA

NA

N

Y

NA

Y

Critically low

 Campbell, 2011 [44]

Y

N

Y

PY

Y

N

N

PY

Y

N

NA

NA

N

Y

NA

Y

Low

 Doyle, 2013 [10]

Y

PY

N

N

N

N

N

Y

N

N

NA

NA

N

Y

NA

Y

Critically low

 Fu, 2016 [37]

Y

N

N

PY

N

N

N

N

N

N

NA

NA

Y

Y

NA

Y

Critically low

 Hulen, 2016 [43]

Y

N

Y

PY

Y

Y

PY

PY

N

N

NA

NA

N

N

NA

Y

Low

 McMurray, 2016 [48]

Y

N

N

Y

Y

Y

N

Y

N

N

NA

NA

N

Y

NA

Y

Critically low

 Wijma, 2017 [24]

Y

PY

Y

Y

N

N

N

Y

Y

N

NA

NA

Y

Y

NA

Y

Moderate

 Raybould, 2018 [45]

Y

N

N

PY

N

Y

N

PY

PY

N

NA

NA

N

N

NA

Y

Low

 Lim, 2019 [36]

Y

PY

Y

PY

Y

Y

N

PY

Y

N

NA

NA

Y

Y

NA

Y

Low

 Connelly, 2019 [42]

Y

PY

Y

PY

N

Y

Y

PY

Y

N

NA

NA

Y

N

NA

Y

Moderate

 Davenport, 2019 [56]

Y

N

Y

PY

Y

Y

N

PY

N

Y

NA

NA

N

Y

NA

Y

Critically low

Systematic reviews with meta-analysis

 O’Neill, 2007 [40]

Y

N

N

N

N

N

N

Y

N

N

Y

N

N

Y

N

Y

Critically low

 Hush, 2011 [51]

Y

PY

Y

PY

N

Y

N

PY

N

N

Y

N

Y

Y

N

N

Low

 Slade, 2014 [49]

Y

N

Y

PY

Y

Y

N

PY

Y

N

Y

N

N

N

N

Y

Low

 O’Keeffe, 2016 [41]

Y

Y

Y

Y

Y

Y

N

PY

PY

N

Y

N

N

Y

N

Y

Low

 Rothmann, 2018 [39]

Y

Y

N

PY

N

N

N

PY

PY

N

Y

N

Y

Y

N

Y

Moderate

 Rossettini, 2018 [53]

Y

Y

Y

PY

Y

Y

Y

Y

Y

N

Y

Y

Y

Y

N

Y

Moderate

  1. aA MeaSurement Tool to Assess systematic Reviews (AMSTAR-2) tool. bcalculated by AMSTAR-2 checklist [36] Y yes, N no, PY partial yes, NA not applicable. cQ2, Q9, Q13 are not applicable for scoping reviews, and Q11, Q12, and Q15 are only applicable for studies with meta-analysis
  2. Q1. Did the research questions and inclusion criteria for the review include the components of PICO? Q2. Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol? Q3. Did the review authors explain their selection of the study designs for inclusion in the review? Q4. Did the review authors use a comprehensive literature search strategy? Q5. Did the review authors perform study selection in duplicate? Q6. Did the review authors perform data extraction in duplicate? Q7. Did the review authors provide a list of excluded studies and justify the exclusions? Q8. Did the review authors describe the included studies in adequate detail? Q9. Did the review authors use a satisfactory technique for assessing the risk of bias in individual studies that were included in the review? Q10. Did the review authors report on the sources of funding for the studies included in the review? Q11. If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? RCTs Q12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? Q13. Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review? Q14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? Q15. If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review? Q16. Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?